Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Bertrand

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Biomacromolecules|October 22, 2014
Vorinostat-polymer conjugate nanoparticles for Acid-responsive delivery and passive tumor targetingIza Denis, Fatima El Bahhaj, Floraine Collette, et al.
European Journal of Medicinal Chemistry|April 2, 2015
Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug deliveryIza Denis, Fatima el Bahhaj, Floraine Collette, et al.
Theranostics|May 11, 2016
Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor TherapyFatima El Bahhaj, Iza Denis, Loic Pichavant, et al.
Neurobiology of Disease|April 11, 2017
NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegenerationAnthony Brureau, Véronique Blanchard-Bregeon, Catherine Pech, et al.
Oncotarget|July 11, 2018
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genesElsa Maitre, Philippe Bertrand, Catherine Maingonnat, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2Dominique Lesuisse, Gilles Dutruc-Rosset, Gilles Tiraboschi, et al.
European Heart Journal. Digital Health|December 4, 2023
Smartphone-based atrial fibrillation screening in the general population: feasibility and impact on medical treatmentHenri Gruwez, Frederik H Verbrugge, Tine Proesmans, et al.
Bioinformatics (Oxford, England)|May 9, 2017
Application of the cghRA framework to the genomic characterization of Diffuse Large B-Cell LymphomaSylvain Mareschal, Philippe Ruminy, Marion Alcantara, et al.
Resuscitation|March 22, 2017
Prevalence of advance directives and impact on advanced life support in out-of-hospital cardiac arrest victimsPaul-Georges Reuter, Jean-Marc Agostinucci, Philippe Bertrand, et al.
Genes, Chromosomes & Cancer|December 12, 2013
Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphomaElodie Bohers, Sylvain Mareschal, Abdelilah Bouzelfen, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Biomacromolecules|October 22, 2014
Vorinostat-polymer conjugate nanoparticles for Acid-responsive delivery and passive tumor targetingIza Denis, Fatima El Bahhaj, Floraine Collette, et al.
European Journal of Medicinal Chemistry|April 2, 2015
Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug deliveryIza Denis, Fatima el Bahhaj, Floraine Collette, et al.
Theranostics|May 11, 2016
Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor TherapyFatima El Bahhaj, Iza Denis, Loic Pichavant, et al.
Neurobiology of Disease|April 11, 2017
NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegenerationAnthony Brureau, Véronique Blanchard-Bregeon, Catherine Pech, et al.
Oncotarget|July 11, 2018
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genesElsa Maitre, Philippe Bertrand, Catherine Maingonnat, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2Dominique Lesuisse, Gilles Dutruc-Rosset, Gilles Tiraboschi, et al.
European Heart Journal. Digital Health|December 4, 2023
Smartphone-based atrial fibrillation screening in the general population: feasibility and impact on medical treatmentHenri Gruwez, Frederik H Verbrugge, Tine Proesmans, et al.
Bioinformatics (Oxford, England)|May 9, 2017
Application of the cghRA framework to the genomic characterization of Diffuse Large B-Cell LymphomaSylvain Mareschal, Philippe Ruminy, Marion Alcantara, et al.
Resuscitation|March 22, 2017
Prevalence of advance directives and impact on advanced life support in out-of-hospital cardiac arrest victimsPaul-Georges Reuter, Jean-Marc Agostinucci, Philippe Bertrand, et al.
Genes, Chromosomes & Cancer|December 12, 2013
Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphomaElodie Bohers, Sylvain Mareschal, Abdelilah Bouzelfen, et al.
Pageof 13